Together, these observations supported a functional role for CHRNA7 in mediating tumor progression, which along with increased CHRNA7 expression in myeloid immune cells, suggesting that CHRNA7 may be a novel therapeutic target. This evidence concerns the gene CHRNA7 and neoplasm.